Profile image
By Market Study Report
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

Outlook of Left Atrial Appendage Closure Market: Research Report from 2017 to 2021

Wednesday, February 15, 2017 6:38
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Left Atrial Appendage Closure analysis is provided for the markets including development trends, competitive landscape analysis, and key regions development status.

Research Analysts Announces the Publication of its Research Report – Global Left Atrial Appendage Closure Market 2017-2021

Research analysts recognizes the following companies as the key players in the global left atrial appendage closure market: AtriCure, Boston Scientific, Coherex Medical, and St. Jude Medical

Other Prominent Vendors in the market are: Occlutech, Lifetech Scientific, and Sentre HEART

The Research analysts forecast the global left atrial appendage closure market to grow at a CAGR of 33.54% during the period 2017-2021.

Complete Left Atrial Appendage Closure Market Report Of 115 Pages Having Tables And Figures Is Available For Purchase @   

Commenting on the report, an analyst from Research Analysts team said: “The increasing clinical trials of research organizations and vendors will expand the application of LAA closure devices by driving the revenue in the market. For new product approval and fulfilled regulatory procedures, it is necessary to carry out clinical trials. Various universities and vendors sponsor this clinical trial. Vendors focus on such trials because positive or negative clinical results of long-term follow-up from trials have an impact on the market. For instance, Novosibirsk Research Institute Of Blood Circulation Pathology and Boston Scientific are conducting a phase II clinical trial to evaluate the safety concern issues of implantation of LAA closure. The process is compared to the standard antiplatelet therapy for the prevention of thromboembolic events and stent thrombosis in individuals with atrial fibrillation who underwent percutaneous coronary intervention.”

According to the report, the growing incidences of atrial fibrillation increase the demand for LAA closure devices. Atrial fibrillation is the most common type of heart arrhythmia in which the heart beats at a rapid and irregular pace. The irregular heart rhythm fluctuates the blood flow from the heart, causing blood to stagnate in the LAA, form clots, and increase the risk of stroke. There are some risk factors such as diabetes, cigarette smoking, obesity, and cardiovascular diseases that lead to atrial fibrillation. LAA closure devices play a pivotal role in managing stroke risk in atrial fibrillation patients. Among the many cardiovascular diseases, atrial fibrillation is a common risk factor, which leads to stroke in some individuals. The LAA closure device is used to close the appendage that occurs in the left atria and reduces the risk of stroke. LAA closure devices are minimally invasive, which offers a novel approach for atrial fibrillation treatment.

The Listed Pricing For This Left Atrial Appendage Closure Market Report Starts At US $3500. Request Discount For Left Atrial Appendage Closure Industry Research Report @   

Further, the report states that rrugs are an alternative treatment option for LAA closure devices. Though these devices are more effective and safer than drugs, they are less preferred. LAA closure device costs are required only once, while costs for warfarin and dabigatran continue to accrue year over year. This factor compels the preference for warfarin and dabigatran by consumers. The drugs used to treat diseases are less invasive in nature. Also, warfarin and dabigatran are used for treatment instead of LAA closure devices, as only a few people are aware of LAA closure devices, and its implants have complicated procedures. Also, the introduction of improved drug delivery techniques and enhanced drug pipelines for the treatment of atrial fibrillation diseases restrict the market growth. Thus, the increased acceptance of warfarin and dabigatran will hamper the growth of the market.

Request A Sample Copy Of Left Atrial Appendage Closure Market Research Report @     

Left Atrial Appendage Closure Market Study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Browse Full Table Of Contents And Data Tables For Left Atrial Appendage Closure Report @        

Related Reports: -
2016 Global Biosurgery Market Status, 2011-2022 Market Historical and Forecasts, Professional Market Research Report
This New Version Biosurgery Market Research Report is a deep market research report in this market. This report focused on global and regional market, major manufacturers, as well as the segment mark…         

About Us:
, a Skyline Market Research LLP brand, is an online aggregator of market research reports. offers a comprehensive collection of full length reports on global and regional markets in 100+ industry verticals. We have partnered with some of the leading business and market research publishing houses and regularly update our online library to offer wide range of reports to our customers.

Contact Us:
Market size forecasters

The Green Suite #4594,
Dover, DE 19901
United States
Phone: 1-201-355-0868
US Toll Free: 1-866-764-2150
Email: [email protected]
Connect with us:
LinkedIn | Twitter 

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.